Meta Platforms, Inc. Equity Method Investments increased by 0.5% to $20.18B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 41073.5%, from $49.00M to $20.18B. Over 5 years (FY 2020 to FY 2025), Equity Method Investments shows an upward trend with a 26.4% CAGR.
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.39B | $6.76B | $34.00M | $34.00M | $34.00M | $33.00M | $17.00M | $18.00M | $59.00M | $59.00M | $58.00M | $57.00M | $56.00M | $53.00M | $52.00M | $49.00M | $2.02B | $5.06B | $20.08B | $20.18B |
| QoQ Change | — | +5.7% | -99.5% | +0.0% | +0.0% | -2.9% | -48.5% | +5.9% | +227.8% | +0.0% | -1.7% | -1.7% | -1.8% | -5.4% | -1.9% | -5.8% | >999% | +150.1% | +297.0% | +0.5% |
| YoY Change | — | — | — | — | -99.5% | -99.5% | -50.0% | -47.1% | +73.5% | +78.8% | +241.2% | +216.7% | -5.1% | -10.2% | -10.3% | -14.0% | >999% | >999% | >999% | >999% |